This paper does not evaluate the impact of aggregate levels on immunogenicity, but seeks to create a useful technique to assess aggregate levels
This retrospective cohort study evaluated TTR 6 months before and after GLP-1 RA initiation using RWD from the TriNetX Research Network
Most people experience significant nausea improvement by week 34, though mild waves may persist until week 68
Patients with IEC-EC have symptoms including severe or prolonged diarrhea, abdominal pain, and weight loss requiring total parenteral (feeding tube) nutrition and treatment with various immunosuppressive therapies, including corticosteroids
When patients lose significant weightparticularly rapidlythe reduced mechanical loading on the skeleton can trigger bone resorption
Medical Records: Pre-treatment health status Diagnosis that led to prescription Documentation of symptoms Diagnostic testing (especially gastric emptying scans) Treatment for complications Hospitalizations and ER visits Current status and ongoing treatment 3